UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
2901
DELISTED
Amicus Therapeutics
FOLD
| $4.83M | ﹤0.01% |
486,767
-411,129
| -46% | -$4.22M |
|
2902
Sabra Healthcare REIT
SBRA
$5.37B
| $4.82M | ﹤0.01% |
312,971
-208,743
| -40% | -$2.98M |
|
2903
State Street SPDR S&P Health Care Equipment ETF
XHE
$163M
| $4.82M | ﹤0.01% |
57,085
+493
| +0.9% | +$41.8K |
|
2904
MGIC Investment
MTG
$6.25B
| $4.81M | ﹤0.01% |
223,411
+55,073
| +33% | +$1.14M |
|
|
AVDX
2905
DELISTED
AvidXchange
AVDX
| $4.81M | ﹤0.01% |
398,983
-197,280
| -33% | -$2.25M |
|
2906
First Industrial Realty Trust
FR
$8.44B
| $4.8M | ﹤0.01% |
101,074
-29,981
| -23% | -$1.44M |
|
2907
InMode
INMD
$880M
| $4.8M | ﹤0.01% |
263,092
-308,906
| -54% | -$5.68M |
|
|
CNR
2908
CALL
Core Natural Resources Inc
CNR
$4.45B
| $4.8M | ﹤0.01% |
47,000
-308,000
| -87% | -$28M |
|
2909
Sumitomo Mitsui Financial
SMFG
$164B
| $4.8M | ﹤0.01% |
357,574
+25,779
| +8% | +$312K |
|
2910
Blue Bird Corp
BLBD
$2.18B
| $4.79M | ﹤0.01% |
88,937
+53,603
| +152% | +$2.47M |
|
2911
Healthcare Realty
HR
$6.84B
| $4.79M | ﹤0.01% |
290,543
-138,758
| -32% | -$2.12M |
|
2912
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
$212M
| $4.78M | ﹤0.01% |
48,458
+3,921
| +9% | +$386K |
|
|
CCC
2913
CCC Intelligent Solutions
CCC
$4.08B
| $4.78M | ﹤0.01% |
429,797
+398,543
| +1,275% | +$4.54M |
|
2914
PUT
Generac Holdings
GNRC
$12.5B
| $4.77M | ﹤0.01% |
36,100
-25,000
| -41% | -$3.46M |
|
2915
Bank of America Series L
BAC.PRL
$3.99B
| $4.77M | ﹤0.01% |
3,990
-98
| -2% | -$115K |
|
2916
Cohen & Steers REIT and Preferred and Income Fund
RNP
$989M
| $4.77M | ﹤0.01% |
234,292
-3,188
| -1% | -$63.9K |
|
2917
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.18B
| $4.77M | ﹤0.01% |
174,641
+35,762
| +26% | +$976K |
|
|
CIM
2918
Chimera Investment
CIM
$1B
| $4.75M | ﹤0.01% |
371,244
+156,693
| +73% | +$1.98M |
|
2919
Radian Group
RDN
$4.93B
| $4.74M | ﹤0.01% |
152,509
-86,153
| -36% | -$2.66M |
|
2920
iShares MSCI Intl Value Factor ETF
IVLU
$4.55B
| $4.74M | ﹤0.01% |
172,847
-167,145
| -49% | -$4.71M |
|
2921
CALL
Franco-Nevada
FNV
$46B
| $4.74M | ﹤0.01% |
40,000
| – | – |
|
2922
CALL
Simon Property Group
SPG
$72.3B
| $4.74M | ﹤0.01% |
31,200
+6,200
| +25% | +$913K |
|
|
2923
PUT
Simon Property Group
SPG
$72.3B
| $4.74M | ﹤0.01% |
31,200
+6,200
| +25% | +$913K |
|
2924
Energizer
ENR
$1.55B
| $4.73M | ﹤0.01% |
160,277
-4,720
| -3% | -$136K |
|
|
SGI
2925
PUT
Somnigroup International
SGI
$13.7B
| $4.73M | ﹤0.01% |
+100,000
| New | +$5.06M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.